Oshrat Rokah-Hershkovitz
Tel Aviv, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Histiocyte Society blueprint for non-Langerhans cell histiocytosis research: unraveling complex diseases through collaboration.
Journal: Haematologica
Published: October 20, 2025
Epigenetic dysregulation in Erdheim-Chester disease: perspectives from tissue and blood.
Journal: Leukemia
Published: August 26, 2025
Loss of miR-146a-5p contributes to ibrutinib resistance in mantle cell lymphoma.
Journal: Blood advances
Published: March 28, 2025
The molecular landscape of AL amyloidosis.
Journal: British journal of haematology
Published: January 24, 2025
RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibition.
Journal: Cancer cell
Published: November 22, 2024
The effect of methylation on the let-7-BCL2L1-BCL2 axis and the potential use of hypomethylating and BH3 mimetic drugs in histiocytic neoplasms.
Journal: Leukemia
Published: September 07, 2024
Novel dual action chimera doxorubizen demonstrates superior efficacy to doxorubicin in acute leukemia.
Journal: Scientific reports
Published: September 05, 2024
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy.
Journal: British journal of haematology
Published: February 05, 2024
Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms.
Journal: Blood advances
Published: November 18, 2022
Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 25, 2022
Non-Coding RNAs in Normal B-Cell Development and in Mantle Cell Lymphoma: From Molecular Mechanism to Biomarker and Therapeutic Agent Potential.
Journal: International journal of molecular sciences
Published: July 29, 2021
Last Updated: 09/26/2026